Literature DB >> 24013580

Hypertensive choroidopathy with eclampsia viewed on spectral-domain optical coherence tomography.

Young-seok Song1, Reiko Kinouchi, Satoshi Ishiko, Katsuhiko Fukui, Akitoshi Yoshida.   

Abstract

PURPOSE: We report a case of hypertensive choroidopathy with detailed retinal images obtained using spectral-domain optical coherence tomography (SD-OCT). CASE: A 19-year-old pregnant woman with no history of high blood pressure had an eclamptic seizure at the 39th week of pregnancy; the baby was delivered by emergency Caesarean section. Six days later, she presented with bilateral blurred vision (best-corrected visual acuity [VA], 0.5, right eye; 0.3, left eye). Bilateral extensive, punctate, pale-yellow Elschnig's spots were present in the posterior fundus. SD-OCT showed a serous retinal detachment (SRD) and retinal pigment epithelium detachment (PED) representing a waveform retinal pigment epithelium (RPE) layer in each eye. The reflective intensity decreased partly at the waveform RPE. A wavy structure suggestive of fibrin was present in both foveas between the photoreceptor ellipsoid zone and the RPE-outer segment line. Four weeks after delivery and oral antihypertensive treatment, the SRDs, PEDs and wavy structure resolved and the VA recovered.
CONCLUSION: SD-OCT visualized SRDs, PEDs, wavy structures under the photoreceptor ellipsoid zone, and areas of low intensity RPE layer in hypertensive choroidopathy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24013580     DOI: 10.1007/s00417-013-2462-9

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  10 in total

1.  Hypertensive choroidopathy: recognizing clinically significant end-organ damage.

Authors:  Marta Ugarte; Simon Horgan; Sal Rassam; Tony Leong; Chee H Kon
Journal:  Acta Ophthalmol       Date:  2007-09-21       Impact factor: 3.761

2.  ACOG technical bulletin. Hypertension in pregnancy. Number 219--January 1996 (replaces no. 91, February 1986). Committee on Technical Bulletins of the American College of Obstetricians and Gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  1996-05       Impact factor: 3.561

3.  Hypertensive choroidopathy in Castleman's disease.

Authors:  David T L Liu; Jerry A Shields; C L Li; H K Ng; Dennis S C Lam
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-06-16       Impact factor: 3.117

4.  Bilateral serous retinal detachments associated with accelerated hypertensive choroidopathy.

Authors:  Yoshio Hirano; Tsutomu Yasukawa; Yuichiro Ogura
Journal:  Int J Hypertens       Date:  2010-09-01       Impact factor: 2.420

Review 5.  Update on the ocular manifestations of systemic arterial hypertension.

Authors:  Betsy P Luo; Gary C Brown
Journal:  Curr Opin Ophthalmol       Date:  2004-06       Impact factor: 3.761

6.  Pathophysiology of hypertensive retinopathy.

Authors:  M O Tso; L M Jampol
Journal:  Ophthalmology       Date:  1982-10       Impact factor: 12.079

7.  Acute Vogt-Koyanagi-Harada disease in enhanced spectral-domain optical coherence tomography.

Authors:  Kenji Ishihara; Masanori Hangai; Mihori Kita; Nagahisa Yoshimura
Journal:  Ophthalmology       Date:  2009-07-30       Impact factor: 12.079

8.  Cerebral artery reactivity changes during pregnancy and the postpartum period: a role in eclampsia?

Authors:  Marilyn J Cipolla; Lisa Vitullo; John McKinnon
Journal:  Am J Physiol Heart Circ Physiol       Date:  2004-01-29       Impact factor: 4.733

9.  Fundus lesions in malignant hypertension. I. A pathologic study of experimental hypertensive choroidopathy.

Authors:  S Kishi; M O Tso; S S Hayreh
Journal:  Arch Ophthalmol       Date:  1985-08

Review 10.  Hypertensive choroidopathy.

Authors:  Karyn Bourke; Milan R Patel; L Michael Prisant; Dennis M Marcus
Journal:  J Clin Hypertens (Greenwich)       Date:  2004-08       Impact factor: 3.738

  10 in total
  9 in total

1.  Extensive choroidal infarction in a case of mixed essential cryoglobulinaemia in a postpartum female.

Authors:  Brijesh Takkar; Shorya Vardhan Azad; Uma Kumar; Pradeep Venkatesh
Journal:  BMJ Case Rep       Date:  2016-09-16

2.  Serous retinal detachment in preeclampsia and malignant hypertension.

Authors:  Christopher Seungkyu Lee; Eun Young Choi; Minsub Lee; Heesuk Kim; Hyewon Chung
Journal:  Eye (Lond)       Date:  2019-05-14       Impact factor: 3.775

3.  Multimodal imaging of hypertensive chorioretinopathy by swept-source optical coherence tomography and optical coherence tomography angiography: Case report.

Authors:  Tryfon Rotsos; Konstantinos Andreanos; Stelios Blounas; Dimitrios Brouzas; Dimitrios S Ladas; Ioannis D Ladas
Journal:  Medicine (Baltimore)       Date:  2017-09       Impact factor: 1.889

4.  Reperfusion of the choriocapillaris observed using optical coherence tomography angiography in hypertensive choroidopathy.

Authors:  Miwa Saito; Akihiro Ishibazawa; Reiko Kinouchi; Akitoshi Yoshida
Journal:  Int Ophthalmol       Date:  2017-09-11       Impact factor: 2.031

Review 5.  A Review of Hypertensive Retinopathy and Chorioretinopathy.

Authors:  Mai Tsukikawa; Andrew W Stacey
Journal:  Clin Optom (Auckl)       Date:  2020-05-05

6.  Choroidal thickening and macular serous retinal detachment in pregnancy-induced hypertension.

Authors:  Ranko Aoyagi; Takaaki Hayashi; Hiroshi Tsuneoka
Journal:  Int Med Case Rep J       Date:  2015-11-11

7.  Bilateral retinal pigment epithelial rips in hypertensive choroidopathy.

Authors:  Yuan-Che Tai; Jerry Chien-Chieh Huang; Chi-Chin Sun; Ling Yeung
Journal:  Taiwan J Ophthalmol       Date:  2015-11-06

8.  Bilateral giant retinal pigment epithelial tears in hypertensive choroidopathy.

Authors:  Natsuki Matsubara; Aki Kato; Aoi Kominami; Miho Nozaki; Tsutomu Yasukawa; Munenori Yoshida; Yuichiro Ogura
Journal:  Am J Ophthalmol Case Rep       Date:  2019-07-24

9.  Pregnancy-induced hypertension-related chorioretinitis resembling uveal effusion syndrome: A case report.

Authors:  Tomohito Sato; Masaru Takeuchi
Journal:  Medicine (Baltimore)       Date:  2018-07       Impact factor: 1.889

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.